Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-25 | 2024-06 | 0 | N/A | N/A | N/A |
2024-05-15 | 2024-03 | 0 | -0.52 | N/A | N/A |
2024-02-14 | 2023-12 | 0 | -0.04 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -1.48 | N/A | N/A |
2023-09-27 | 2023-06 | 0 | 0.16 | N/A | N/A |
2023-05-11 | 2023-03 | 0 | -1.93 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-08 | Maxim Group | Upgrade | Buy | |
2023-05-30 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-04-15 | CANTRELL GARY V. | Director | 204.09K | Stock Award(Grant) |
2023-06-13 | DISBROW JOSHUA R. | Chief Executive Officer | 71.59K | Purchase |
2023-08-10 | DOCKERY CARL C | Director | 8.94K | Stock Award(Grant) |
2021-04-07 | HECHT BETH P | Director | 9.05K | Stock Award(Grant) |
2023-08-15 | JAIN ABHINAV | Director | 8.00K | Stock Award(Grant) |
2023-08-10 | LIU VIVIAN H | Director | 1.84K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Nantahala Capital Management, LLC | 1.09M | 1.74M | 19.65% |
2023-06-29 | Stonepine Capital Management, LLC | 472.37K | 755.79K | 8.54% |
2023-06-29 | Renaissance Technologies, LLC | 57.32K | 91.72K | 1.04% |
2023-06-29 | Blackrock Inc. | 24.06K | 38.49K | 0.44% |
2023-06-29 | Acadian Asset Management. LLC | 22.54K | 36.06K | 0.41% |
2023-06-29 | Prudential Financial, Inc. | 19.58K | 31.32K | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 9.99K | 15.99K | 0.18% |
2023-05-30 | Fidelity Extended Market Index Fund | 8.71K | 14.55K | 0.16% |
2023-05-30 | Fidelity Series Total Market Index Fund | 1.59K | 2.66K | 0.03% |
2023-05-30 | Fidelity Total Market Index Fund | 1.59K | 2.65K | 0.03% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 1.27K | 2.15K | 0.02% |
Split | Date |
---|---|
1 : 20 | 2023-01-06 |
1 : 10 | 2020-12-09 |
1 : 20 | 2018-08-13 |
1 : 20 | 2017-08-29 |
1 : 12 | 2016-07-01 |
82 : 1000 | 2015-06-10 |
-
-
Sold to grab more at $XSPA. Come back later
-
-
April 20th and we are in May 20th
In the conference call AYTU left all Covid 19 off the books. No reports of income as this is on the next earnings report. The call was very BLAND with tone and nothing off the wall came out other than they are profitable for the 1st quarter.
I have my doubts as the FDA has not been working with some companies. Mostly BIG Corps are getting the attention and folks who have a cure. The investors are really left in the dark on any findings and as stated they are not going to say how many kits are sold or in inventory. We will see in the coming months but now another month gone without FDA approval for test kit or Healight.
-
-
Thinking at this rate the stock should become SSR $.15 by July 4th
Let em keep shorting and running away investors. Not loosing money in this stock anymore.
BARCODE SSR dream stock!!
-
3 months here from 1$ x share I have 2k shares we coming up
-
Nice barcode...
looking like 1.35 by end of day... Go SSR -
Sabby shorts stocks they are used to come in and control price action. Typically once they leave it goes. Just my last experience in sabby stocks. Hopefully fda comes through with light and we take off !!!
-
-
-
Playing this for healight if pharma let’s it out the bag. It will. Trump’s uncle received healight tech from Tesla when he got his research at MiT when tesla passed hundred years ago. Trump will make sure old tech gets released imo.
-
Welcome back HOME $AYTU
Back to the 1.55 congratulations! -
Wow not under 1.60 yet
I’m actually shocked should be there by end of day and then stable at 1.55Amazing Barcode Stock to the T
-
-
Yes it is... AYTU Has a barcode history.
Follow the barcode for buying shares. I forgot to set me sell after market and lost some profit but I did break even.Coming back on board in the 1.50 plus range. It will hit it tomorrow and then the SSR are back in. I believe in this company and I think the board members are have a lot to chew on. Going to be A Great Company and hope it turns over 250mm by year end. 2 years it is a billion dollar company!
-
Company very strong.
No Covid money was reported for the first half and they said they have already sold kits and those sales are on the next report release.Very Strong Company on the books and plenty of cash flow for growth. Expect huge numbers next quarterly review and we should hear about Healight soon.
-
Back to 1.60
I will buy in on that price.
Great Future outlook and the barcode makes it easy to sell and buy back in. See you tomorrow for buy back in of 1.55 to 1.60
-
Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
accesswire.com • -
Best Penny Stocks? 4 Hot Stocks With News This Week
pennystocks.com • -
Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript
seekingalpha.com •